Diabetic macular edema: current and emerging therapies.

ABSTRACT: Diabetic macular edema is a leading cause of vision impairment among people within the working- age population. This review discusses the pathogenesis of diabetic macular edema and the treatment options currently available for the treatment of diabetic macular edema, including for focal/grid photocoagulation, intravitreal corticosteroids and intravitreal anti-vascular endothelial growth factor agents. The biologic rationale for novel therapeutic agents, many of which are currently being evaluated in clinical trials, also is reviewed.

SUBMITTER: Wenick AS 

PROVIDER: S-EPMC3277023 | biostudies-other | 2012 Jan

REPOSITORIES: biostudies-other